We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Cigna Group’s (CI - Free Report) Evernorth Health Services recently announced its acquisition of Bright.md, adding to MDLIVE’s virtual care capabilities. The acquiree is a leader in asynchronous care, healthcare navigation services and triage. It is a suitable pick for Evernorth to enhance MDLIVE, its virtual care platform, with Bright.md’s technological and clinical capabilities.
This move bodes well for Evernorth as it would improve health outcomes and the experience of patients by improving patient access to quality care, saving clinicians time and reducing the cost of providing care. An improvement in patient health outcomes and meaningful interactions between patients and providers would enhance Evernorth’s core value proposition by enhancing its offerings. Evernorth is also enhancing its MDLIVE platform by adding health coaching for patients suffering from chronic conditions. The company expects the Evernorth Health Services segment to report adjusted operating income on a pretax basis of a minimum of $6.4 billion in 2023.
The company aims to provide care efficiently while reducing the cost of care. Hence, with this acquisition, it will be able to provide asynchronous care within MDLIVE through which patients can get access to care without the need for physical interaction. This service will be available for patients in 2024 and is expected to extend its benefits to support chronic disease management in the future.
Such investments by the company highlight its unwavering focus on addressing health issues holistically and diversifying the avenues through which patients get access to care. A clinical digital interview will be taken and converted into a holistic chart and the clinician can go through the responses and provide diagnosis, prescriptions and care plans accordingly.
Evernorth is also introducing health coaching as part of a patient care plan developed by a primary care physician. This move will support patients with chronic conditions and help providers manage lifestyle changes of patients, ultimately improving patient outcomes.
Shares of Cigna have gained 11.9% in the past six months compared with the industry’s 1.9% growth. CI currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Select Medical’s 2023 earnings indicates a 56.9% year-over-year increase to $1.93 per share. It has witnessed one upward estimate revision in the past 60 days against no movement in the opposite direction. The consensus mark for SEM’s 2023 revenues indicates 4.2% growth from a year ago.
The Zacks Consensus Estimate for HCA Healthcare’s 2023 bottom line suggests a 9.4% increase from the prior-year levels. HCA has witnessed one upward estimate revision in the past week against none in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with the average surprise being 5.4%.
The Zacks Consensus Estimate for Atai Life Sciences’ current-year earnings implies a 16.3% improvement from the year-ago reported figure. It has witnessed four upward estimate revisions in the past 60 days against no movement in the opposite direction. ATAI beat earnings estimates in two of the last four quarters, met once and missed on one occasion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Cigna's (CI) Evernorth Acquires Bright.md Technology Platform
The Cigna Group’s (CI - Free Report) Evernorth Health Services recently announced its acquisition of Bright.md, adding to MDLIVE’s virtual care capabilities. The acquiree is a leader in asynchronous care, healthcare navigation services and triage. It is a suitable pick for Evernorth to enhance MDLIVE, its virtual care platform, with Bright.md’s technological and clinical capabilities.
This move bodes well for Evernorth as it would improve health outcomes and the experience of patients by improving patient access to quality care, saving clinicians time and reducing the cost of providing care. An improvement in patient health outcomes and meaningful interactions between patients and providers would enhance Evernorth’s core value proposition by enhancing its offerings. Evernorth is also enhancing its MDLIVE platform by adding health coaching for patients suffering from chronic conditions. The company expects the Evernorth Health Services segment to report adjusted operating income on a pretax basis of a minimum of $6.4 billion in 2023.
The company aims to provide care efficiently while reducing the cost of care. Hence, with this acquisition, it will be able to provide asynchronous care within MDLIVE through which patients can get access to care without the need for physical interaction. This service will be available for patients in 2024 and is expected to extend its benefits to support chronic disease management in the future.
Such investments by the company highlight its unwavering focus on addressing health issues holistically and diversifying the avenues through which patients get access to care. A clinical digital interview will be taken and converted into a holistic chart and the clinician can go through the responses and provide diagnosis, prescriptions and care plans accordingly.
Evernorth is also introducing health coaching as part of a patient care plan developed by a primary care physician. This move will support patients with chronic conditions and help providers manage lifestyle changes of patients, ultimately improving patient outcomes.
Shares of Cigna have gained 11.9% in the past six months compared with the industry’s 1.9% growth. CI currently carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the medical space are Select Medical Holdings Corporation (SEM - Free Report) , HCA Healthcare, Inc. (HCA - Free Report) and Atai Life Sciences N.V. (ATAI - Free Report) . While Select Medical sports a Zacks Rank #1 (Strong Buy), HCA Healthcare and Atai Life Sciences carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Select Medical’s 2023 earnings indicates a 56.9% year-over-year increase to $1.93 per share. It has witnessed one upward estimate revision in the past 60 days against no movement in the opposite direction. The consensus mark for SEM’s 2023 revenues indicates 4.2% growth from a year ago.
The Zacks Consensus Estimate for HCA Healthcare’s 2023 bottom line suggests a 9.4% increase from the prior-year levels. HCA has witnessed one upward estimate revision in the past week against none in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with the average surprise being 5.4%.
The Zacks Consensus Estimate for Atai Life Sciences’ current-year earnings implies a 16.3% improvement from the year-ago reported figure. It has witnessed four upward estimate revisions in the past 60 days against no movement in the opposite direction. ATAI beat earnings estimates in two of the last four quarters, met once and missed on one occasion.